Corcept Therapeutics Incorporated (CORT : NASDAQ)
Common Stock
$118.51
USD
+5.57 (4.93%)
Last updated: 2026-09-24
Follow CORT
CORT
Corcept Therapeutics Incorporated
WealthAwesomePerformance
1 Day
+4.93%
1 Week
+3.18%
1 Month
-4.09%
YTD
+44.97%
Key Statistics
Market Cap
$12.81B
52W High
$126.38
52W Low
$28.66
P/E Ratio
252.15
50 Day MA
$110.26
200 Day MA
$69.03
Beta
0.45
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/24/2026 | $111.86 | $119.15 | $111.68 | $118.51 | $118.51 | 983,631 |
| 9/23/2026 | $117.33 | $118.79 | $112.05 | $112.94 | $112.94 | 794,376 |
| 9/22/2026 | $113.96 | $119.00 | $113.09 | $117.50 | $117.50 | 810,249 |
| 9/21/2026 | $110.29 | $116.65 | $109.00 | $113.76 | $113.76 | 1,245,364 |
| 9/18/2026 | $116.80 | $117.90 | $108.41 | $110.29 | $110.29 | 17,233,200 |
| 9/17/2026 | $113.18 | $115.09 | $111.07 | $114.86 | $114.86 | 853,293 |
| 9/16/2026 | $110.82 | $113.60 | $110.49 | $111.81 | $111.81 | 648,634 |
| 9/15/2026 | $111.97 | $112.80 | $109.40 | $110.82 | $110.82 | 1,458,661 |
| 9/14/2026 | $113.38 | $114.52 | $111.10 | $111.80 | $111.80 | 1,230,701 |
| 9/11/2026 | $115.22 | $117.84 | $109.30 | $112.79 | $112.79 | 1,282,453 |
Analyst Price Targets
Based on 6 analysts covering CORT · as of Sep 17, 2026
Wall Street analysts forecast CORT stock price to rise 19.0% over the next 12 months.
Consensus
Strong Buy4.50 / 5.00
Avg. Target
US$141.00
+19.0% Upside
Current Price
US$118.51
Last close
Analyst Breakdown (6 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CORT's historical volatility
30-Day Vol
36.8%
Annualized
90-Day Vol
61.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$141.68
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$125.78 | US$110.79 – US$142.80 |
| 60 trading days | US$133.49 | US$111.56 – US$159.74 |
| 90 trading days | US$141.68 | US$113.72 – US$176.51 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.
Financials
- Revenue (TTM)
- $830.81M
- EBITDA
- $8.08M
- Profit Margin
- 6.64%
- ROE (TTM)
- 8.23%
- EPS (Diluted)
- 0.47
- Book Value
- 6.54
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CORT.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RPGL | Republic Power Group Limited Class A Ordinary Shares | $14.69 | +1363.23% |
| KITT | Nauticus Robotics Inc. | $2.93 | +459.21% |
| ZWZZT | NASDAQ TEST STOCK | $24.50 | +144.51% |
| SRZN | Surrozen Inc | $33.68 | +108.42% |
| GLND | Greenland Energy Company Common Stock | $5.35 | +83.85% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.65 | +80.62% |
| STAK | STAK Inc. Ordinary Shares | $1.44 | +53.19% |
| PFSA | Profusa, Inc. Common Stock | $3.03 | +47.80% |
CORT.US news timeline
1 article covering CORT.US, most recent first
Latest